Pro Dex PDEX
NASDAQ PDEX
$65.67 -0.64 (-0.97%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pro Dex (PDEX) Liabilities and Shareholders Equity (2011 - 2026)

Pro Dex (PDEX) posted Liabilities and Shareholders Equity of $75.0 million for Q1 2026, up 20.43% sequentially from $62.3 million in Q4 2025, and up 16.65% YoY from $64.3 million in Q1 2025.

Pro Dex (PDEX) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Pro Dex has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $75.0 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 16.65% year-over-year to $75.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262.7 million (up 13.52% YoY) and the FY2025 annual result came in at $61.2 million, up 16.61% from the prior year.
  • Liabilities and Shareholders Equity climbed to $75.0 million in Q1 2026 per PDEX's latest filing, from $62.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $75.0 million in Q1 2026 and troughed at $45.2 million in Q1 2022.
  • A 5-year average of $55.6 million and a median of $51.9 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity decreased 2.21% in 2024, then rose 27.15% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $51.9 million in 2022, then decreased by 0.87% to $51.4 million in 2023, then advanced by 17.4% to $60.4 million in 2024, then grew by 3.12% to $62.3 million in 2025, then rose by 20.43% to $75.0 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $75.0 million, $62.3 million, and $64.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Pro Dex 209.47 Mn 198.49 Mn 6.13 Mn 74.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 74.98 Mn
Dec 31, 2025 62.26 Mn
Sep 30, 2025 64.30 Mn
Jun 30, 2025 61.19 Mn
Mar 31, 2025 64.27 Mn
Dec 31, 2024 60.37 Mn
Sep 30, 2024 54.31 Mn
Jun 30, 2024 52.48 Mn
Mar 31, 2024 50.55 Mn
Dec 31, 2023 51.43 Mn
Sep 30, 2023 49.59 Mn
Jun 30, 2023 51.82 Mn
Mar 31, 2023 51.69 Mn
Dec 31, 2022 51.88 Mn
Sep 30, 2022 49.86 Mn
Jun 30, 2022 49.09 Mn
Mar 31, 2022 45.22 Mn
Dec 31, 2021 43.33 Mn
Sep 30, 2021 42.93 Mn
Jun 30, 2021 40.32 Mn